Re: SP 52 week low
in response to
by
posted on
Oct 06, 2022 09:46AM
Narmac are you suggesting that having Apabetalone on the market could or will hurt existing drugs sales in different indications thus BP has a vested interest in burying this technology? That being said, any BP could just buyout RVX and do whatever they want with the IP.